The goals of this study were to compare the efficacy of once-daily administered
Glargine insulin to twice-daily administered
Lente insulin in cats with
diabetes mellitus and to describe the use of a
high-protein, low-carbohydrate diet designed for the management of
diabetes mellitus in cats. All cats with naturally occurring
diabetes mellitus were eligible for inclusion. Baseline testing included a physical examination, serum biochemistry, urinalysis and urine culture, serum
thyroxine concentration, and serum
fructosamine concentration. All cats were fed the
high-protein, low-carbohydrate diet exclusively. Cats were randomized to receive either 0.5 U/kg
Lente insulin q12h or 0.5 U/kg
Glargine insulin q24h. Re-evaluations were performed on all cats at weeks 1, 2, 4, 8, and 12, and included an assessment of clinical signs, physical examination, 16-hour
blood glucose curve, and serum
fructosamine concentrations. Thirteen cats completed the study (Lente, n = 7,
Glargine, n = 6). There was significant improvement in serum
fructosamine and
glucose concentrations in all cats but there was no significant difference between the 2
insulin groups. Four of the 13 cats were
in complete remission by the end of the study period (Lente, n = 3;
Glargine, n = 1). The results of the study support the use of once-daily
insulin Glargine or twice-daily
Lente insulin in combination with a
high-protein, low-carbohydrate diet for treatment of feline
diabetes mellitus.